Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

$ 15.50

4.8
(229)
In stock
Description

Irritable bowel syndrome - Wikipedia

JCM, Free Full-Text

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Clinical Diabetes and Endocrinology

Carcinoid Tumour

Inhibition of Peripheral Synthesis of Serotonin as a New Target in

Management of Diarrhea in Patients With Carcinoid Syndrome. - Abstract - Europe PMC

JCM, Free Full-Text

Recent Advances in the Diagnosis and Management of Carcinoid Syndrome - ScienceDirect

Time to Sustained Improvement in Bowel Movement Frequency with

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I

Complications from carcinoid syndrome: review of the current

Irritable bowel syndrome - Wikipedia

Management of Diarrhea in Patients With Carcinoid Syndrome. - Abstract - Europe PMC